T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.4% |
| 2 | Healthcare | 16.1% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Adient
ADNT
$1.58B
| $32.2M | ﹤0.01% |
672,849
-2,976
| -0.4% | -$133K |
|
1152
Xylem
XYL
$27.9B
| $32.1M | ﹤0.01% |
268,036
-10,709
| -4% | -$1.33M |
|
1153
Quest Diagnostics
DGX
$25.9B
| $32M | ﹤0.01% |
184,790
-5,376
| -3% | -$818K |
|
1154
Baker Hughes
BKR
$64B
| $31.5M | ﹤0.01% |
1,309,984
+24,301
| +2% | +$600K |
|
1155
H.B. Fuller
FUL
$3.32B
| $31.5M | ﹤0.01% |
388,369
+4,776
| +1% | +$353K |
|
1156
Regions Financial
RF
$27.1B
| $31.5M | ﹤0.01% |
1,442,769
-72,574
| -5% | -$1.66M |
|
1157
iShares Core MSCI EAFE ETF
IEFA
$196B
| $31.4M | ﹤0.01% |
421,343
+153,138
| +57% | +$11.5M |
|
1158
Hewlett Packard
HPE
$78.7B
| $31.4M | ﹤0.01% |
1,993,146
-66,325
| -3% | -$1M |
|
1159
Ryman Hospitality Properties
RHP
$7.99B
| $31.4M | ﹤0.01% |
341,796
-29,735
| -8% | -$2.55M |
|
1160
Main Street Capital
MAIN
$5.51B
| $31.3M | ﹤0.01% |
697,689
-58,485
| -8% | -$2.57M |
|
|
PSPC.U
1161
DELISTED
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
| $31.3M | ﹤0.01% |
2,952,376
-64,700
| -2% | -$654K |
|
1162
Lumentum
LITE
$83.3B
| $31.2M | ﹤0.01% |
295,261
+73,194
| +33% | +$6.66M |
|
1163
International Seaways
INSW
$4.76B
| $31.2M | ﹤0.01% |
2,126,649
-37,224
| -2% | -$616K |
|
|
PVBC
1164
DELISTED
Provident Bancorp
PVBC
| $31.2M | ﹤0.01% |
1,677,286
-200
| -0% | -$3.6K |
|
1165
Novavax
NVAX
$1.31B
| $31.1M | ﹤0.01% |
217,357
-248,562
| -53% | -$42.7M |
|
1166
NetApp
NTAP
$40.1B
| $30.9M | ﹤0.01% |
335,510
-7,314
| -2% | -$659K |
|
|
GRMN
1167
Garmin
GRMN
$60.2B
| $30.5M | ﹤0.01% |
224,090
-7,422
| -3% | -$1.07M |
|
1168
M&T Bank
MTB
$36.8B
| $30.4M | ﹤0.01% |
197,694
-7,098
| -3% | -$1.09M |
|
1169
Western Digital
WDC
$173B
| $30.4M | ﹤0.01% |
615,895
-25,018
| -4% | -$1.09M |
|
1170
Ventas
VTR
$46.5B
| $30.3M | ﹤0.01% |
593,589
-10,615
| -2% | -$555K |
|
1171
Blue Bird Corp
BLBD
$2.09B
| $30.3M | ﹤0.01% |
1,940,117
-28,281
| -1% | -$561K |
|
1172
NerdWallet
NRDS
$629M
| $30.2M | ﹤0.01% |
+1,996,578
| New | +$39.1M |
|
1173
Darden Restaurants
DRI
$25.4B
| $30.2M | ﹤0.01% |
200,411
-12,422
| -6% | -$1.84M |
|
1174
Cleveland-Cliffs
CLF
$6.9B
| $30.2M | ﹤0.01% |
1,385,234
+503,575
| +57% | +$10.8M |
|
1175
Five Star Bancorp
FSBC
$1.16B
| $30.1M | ﹤0.01% |
1,004,597
-8,148
| -0.8% | -$229K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.